CCL18 and systemic sclerosis: CCL18, a potent chemoattractant for lymphocytes, is significantly expressed in patients suffering from chronic inflammatory diseases and altered levels of this chemokine have been noticed as a prognosis element for lung disease progression and mortality in SSc patients (19, 20, 54).